Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Eric G. Bluemn, Ilsa M. Coleman, Jared M. Lucas, et al.
Cancer Cell (2017) Vol. 32, Iss. 4, pp. 474-489.e6
Open Access | Times Cited: 639

Showing 1-25 of 639 citing articles:

Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida, Joanna Cyrta, Glenn Heller, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 23, pp. 11428-11436
Open Access | Times Cited: 1135
Genetics and biology of prostate cancer
Guocan Wang, Di Zhao, Denise J. Spring, et al.
Genes & Development (2018) Vol. 32, Iss. 17-18, pp. 1105-1140
Open Access | Times Cited: 634
Lineage plasticity in cancer: a shared pathway of therapeutic resistance
Àlvaro Quintanal-Villalonga, Joseph M. Chan, Helena A. Yu, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 6, pp. 360-371
Open Access | Times Cited: 394
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
Alastair Davies, Himisha Beltran, Amina Zoubeidi
Nature Reviews Urology (2018) Vol. 15, Iss. 5, pp. 271-286
Closed Access | Times Cited: 355
Genomic and phenotypic heterogeneity in prostate cancer
Michael C. Haffner, Wilbert Zwart, Martine P. Roudier, et al.
Nature Reviews Urology (2020) Vol. 18, Iss. 2, pp. 79-92
Open Access | Times Cited: 354
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 10, pp. 4492-4505
Open Access | Times Cited: 346
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing
Srinivas R. Viswanathan, Gavin Ha, Andreas Hoff, et al.
Cell (2018) Vol. 174, Iss. 2, pp. 433-447.e19
Open Access | Times Cited: 329
Patient derived organoids to model rare prostate cancer phenotypes
Loredana Puca, Rohan Bareja, Davide Prandi, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 304
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
Himisha Beltran, Andrew M. Hruszkewycz, Howard I. Scher, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 23, pp. 6916-6924
Open Access | Times Cited: 296
Clinical features of neuroendocrine prostate cancer
Vincenza Conteduca, Clara Oromendia, Kenneth Eng, et al.
European Journal of Cancer (2019) Vol. 121, pp. 7-18
Open Access | Times Cited: 269
Biologically informed deep neural network for prostate cancer discovery
Haitham Elmarakeby, Justin H. Hwang, Rand Arafeh, et al.
Nature (2021) Vol. 598, Iss. 7880, pp. 348-352
Open Access | Times Cited: 266
Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
Meghan A. Rice, Sanjay V. Malhotra, Tanya Stoyanova
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 262
Recent Advances in Prostate Cancer Treatment and Drug Discovery
Ekaterina Nevedomskaya, Simon J. Baumgart, Bernard Haendler
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1359-1359
Open Access | Times Cited: 232
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
Himisha Beltran, Clara Oromendia, Daniel C. Danila, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 1, pp. 43-51
Open Access | Times Cited: 231
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
Lauren Brady, Michelle Kriner, Ilsa M. Coleman, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 225
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
Michael D. Nyquist, Alexandra Corella, Ilsa M. Coleman, et al.
Cell Reports (2020) Vol. 31, Iss. 8, pp. 107669-107669
Open Access | Times Cited: 221
Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer
Ali Ghoochani, En‐Chi Hsu, Merve Aslan, et al.
Cancer Research (2021) Vol. 81, Iss. 6, pp. 1583-1594
Open Access | Times Cited: 215
ONECUT2 is a driver of neuroendocrine prostate cancer
Haiyang Guo, Xinpei Ci, Musaddeque Ahmed, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 207
Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling
Joseph M. Chan, Samir Zaidi, Jillian Love, et al.
Science (2022) Vol. 377, Iss. 6611, pp. 1180-1191
Open Access | Times Cited: 202
Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
Zeda Zhang, Wouter R. Karthaus, Young Sun Lee, et al.
Cancer Cell (2020) Vol. 38, Iss. 2, pp. 279-296.e9
Open Access | Times Cited: 199
Towards precision oncology in advanced prostate cancer
Sheng‐Yu Ku, Martin Gleave, Himisha Beltran
Nature Reviews Urology (2019) Vol. 16, Iss. 11, pp. 645-654
Open Access | Times Cited: 195
Clinical and Biological Features of Neuroendocrine Prostate Cancer
Yasutaka Yamada, Himisha Beltran
Current Oncology Reports (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 193
Spatially resolved clonal copy number alterations in benign and malignant tissue
Andrew Erickson, Mengxiao He, Emelie Berglund, et al.
Nature (2022) Vol. 608, Iss. 7922, pp. 360-367
Open Access | Times Cited: 191
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression
Wenjing Su, Hyun Ho Han, Yan Wang, et al.
Cancer Cell (2019) Vol. 36, Iss. 2, pp. 139-155.e10
Open Access | Times Cited: 178
Non-canonical functions of the RB protein in cancer
Frederick A. Dick, David W. Goodrich, Julien Sage, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 7, pp. 442-451
Open Access | Times Cited: 162
Page 1 - Next Page

Scroll to top